BioneerCorp
KOSDAQ:064550
BioneerCorp
BIONEER Corp. engages in the manufacture and sale of biotechnological products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-12-29. The firm mainly focuses on the development of deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits and other services, such as DNA and ribonucleic acid (RNA) amplification products, Oligo synthesis and reagents, gene synthesis services, gene expressions, protein expressions and purifications, genomics services, human diagnostics kits, veterinary diagnostics kits and others. The company also provides DNA devices, including DNA extraction, amplification and quantitative analysis devices and other DNA diagnostic devices, and supplies for tests and others. In addition, it provides equipment and supplies used for biotechnology research. The firm operates its business within domestic market and in overseas markets, including America, China, Japan, India, Africa and others.
BIONEER Corp. engages in the manufacture and sale of biotechnological products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-12-29. The firm mainly focuses on the development of deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits and other services, such as DNA and ribonucleic acid (RNA) amplification products, Oligo synthesis and reagents, gene synthesis services, gene expressions, protein expressions and purifications, genomics services, human diagnostics kits, veterinary diagnostics kits and others. The company also provides DNA devices, including DNA extraction, amplification and quantitative analysis devices and other DNA diagnostic devices, and supplies for tests and others. In addition, it provides equipment and supplies used for biotechnology research. The firm operates its business within domestic market and in overseas markets, including America, China, Japan, India, Africa and others.
